Prolonged QT interval in ST-elevation myocardial infarction: predictors and prognostic value in medium-term follow-up

Alessandro Galluzzo1, Cristina Gallo, Alberto Battaglia

  • 1Division of Cardiology, Department of Medical Sciences, Città della Salute e della Scienza Hospital, University of Turin, Italy.

Insights

A prolonged corrected QT interval (≥480 ms) in ST-elevation myocardial infarction predicts cardiovascular death. Combining this with low ejection fraction improves risk prediction accuracy for better patient outcomes.

Area of Science:

  • Cardiology
  • Clinical Electrophysiology
  • Cardiovascular Medicine

Background:

  • The prognostic significance of the corrected QT interval (QTc) in ST-elevation myocardial infarction (STEMI) remains under investigation.
  • Early identification of high-risk patients post-STEMI is crucial for timely intervention and improved survival.

Purpose of the Study:

  • To evaluate the prognostic value of a prolonged corrected QT interval (≥480 ms) in patients with acute coronary syndrome, specifically STEMI.
  • To determine if QTc prolongation independently predicts adverse cardiovascular outcomes.

Main Methods:

  • Prospective enrollment of 185 consecutive STEMI patients.
  • Continuous electrocardiographic monitoring of the corrected QT interval throughout hospitalization.
  • Univariate and multivariate analyses to assess the association between QTc interval and cardiovascular events.

Main Results:

  • A prolonged QTc interval (≥480 ms) was significantly associated with cardiovascular death, aborted sudden cardiac death, cerebral ischemic stroke, and recurrent myocardial infarction.
  • Multivariate analysis identified QTc prolongation as an independent predictor of cardiovascular death (OR 6.38, P=0.004), alongside reduced ejection fraction (≤35%, OR 4.20, P=0.021).
  • The combined assessment of QTc interval and ejection fraction significantly enhanced the accuracy (AUC 0.83) for predicting cardiovascular death.

Conclusions:

  • A QTc interval peak of ≥480 ms during the acute phase of STEMI is an independent predictor of cardiovascular mortality.
  • The combination of prolonged QTc interval and reduced ejection fraction (≤35%) improves risk stratification accuracy in STEMI patients.
  • These findings highlight the importance of QTc interval monitoring for risk assessment in STEMI management.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
426
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
7.8K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
727
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
957
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K